Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trials

Find Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trials Near You

Five Digits Test - Validation of a Neuropsychological Test of Inhibition for Patients With Neuropsychiatric Conditions

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Neuropsychiatric conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and autism are characterized by specific deficits in cognitive functions. Thus, neuropsychological assessment is a critical part of the diagnostic process for these conditions. Inhibition is a specific function of interest during these examinations, since it is often affected in patients with ADHD and/or autism. The Five Digits Test (FDT) is a newly developed test measuring inhibition, without requirements of reading ability, and only limited requirements of language proficiency. The aim of this study is to investigate the validity of the FDT in patients with neuropsychiatric conditions. The FDT will be validated using the following research questions: 1. Is the FDT equivalent to the standard neuropsychological test of inhibition, the Color-Word Interference Test from the Delis-Kaplan Executive Function System in patients with neuropsychiatric conditions? (Convergent validity) 2. Is the FDT consistent with self-assessment of inhibition and behavioral regulation in every day life using the Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A)? (Ecological validity) 3. Are there differences in validity in the first two research questions due to language background or due to reading and writing difficulties? 4. Are there differences between patients with neuropsychiatric conditions and healthy controls in the performance of the FDT?

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• age 18 and above

• Diagnosed with a ADHD or Autism, alternatively under examination these diagnoses

Locations
Other Locations
Sweden
Umeå University, Umeå University Hospital
RECRUITING
Umeå
Contact Information
Primary
Nils Berginström, PhD
nils.berginstrom@umu.se
+46907868864
Time Frame
Start Date: 2026-01-21
Estimated Completion Date: 2027-12
Participants
Target number of participants: 150
Treatments
ADHD
Patients with Attention Deficit Hyperactivity Disorder (ADHD)
Autism
Patients with Autism
Healthy Controls
Healthy Controls
Sponsors
Leads: Umeå University
Collaborators: Region Västerbotten

This content was sourced from clinicaltrials.gov